Ledger.Open graph →
SEC Form D · filed November 29, 2021

Kala Pharmaceuticals, Inc

Offering
$36.5M
Sold
$16.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Gregory D. Grunberg · Watertown, MADirectorMark S. Blumenkranz · Watertown, MADirectorMary Reumuth · Watertown, MAExecHoward B. Rosen · Watertown, MADirectorKim Brazzell · Watertown, MAExecAndrew L. Koven · Watertown, MADirectorRobert D. Paull · Watertown, MADirectorEric L. Trachtenberg · MONTREAL, Quebec, CanadaExecTodd Bazemore · Watertown, MAExecHongming Chen · Watertown, MAExecEric L. Trachtenberg · Vancouver, British Columbia, CanadaExecKim Brazzell · Watertown, MAExecDarius D. Kharabi · Watertown, MAExecGregory D. Grunberg · Watertown, MADirectorDarius D. Kharabi · Watertown, MAExecMark Iwicki · South San Francisco, CAExec · DirectorRobert D. Paull · Watertown, MADirectorMary Reumuth · Watertown, MAExecC. D. Myers · Alpharetta, GADirectorTodd Bazemore · Watertown, MAExecC. D. Myers · Alpharetta, GADirectorMark S. Blumenkranz · San Francisco, CADirectorGregory D. Perry · Cambridge, MADirectorGregory D. Perry · Cambridge, MADirectorAndrew L. Koven · Watertown, MADirectorHoward B. Rosen · Redwood City, CADirectorMark Iwicki · CHELSEA, MAExec · DirectorHongming Chen · Waltham, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗